Abstract: A control device is configured to perform: performing a first process when an index value indicating a degree of closeness to a risky object which is present in front of a mobile object is less than a first threshold value; performing a second process when the index value is equal to or greater than the first threshold value and less than a second threshold value greater than the first threshold value; and performing a third process and the second process when the index value is equal to or greater than the second threshold value. The third process includes a fourth process of proposing a driving operation for avoiding the risky object to a driver. The fourth process is not performed when the driver has performed an action for reducing or releasing an operation of an operator instructing an accelerating operation for accelerating the mobile object.

Abstract: A control device of an embodiment is a control device that makes a proposal for steering to avoid a risk object present on a traveling direction side of a mobile object to a driver of the mobile object and includes a determiner configured to determine, when it is assumed that the mobile object is caused to travel straight from a current position of the mobile object in a current traveling direction for a predetermined time, whether an assumed reference position of the mobile object intersects a traveling road boundary, and a proposer configured to suppress the proposal when it is determined that the reference position intersects the traveling road boundary, and makes the proposal when it is determined that the reference position does not intersect the traveling road boundary.

Abstract: An automatic travel system includes a prohibition boundary line setter to set a prohibition boundary line beyond which the vehicle is prohibited from entering, a turning circle setter to set a virtual turning circle as a target route for entry turning travel to enter a subsequent travel route, a transition turning travel controller to control tangent following travel using a vehicle body reference point that is calculated during travel to the virtual turning circle as a target orientation, and the entry turning travel using the virtual turning circle as a turning target route, an interference boundary line detector to detect the prohibition boundary line that is present in a moving direction of the vehicle in the tangent following travel, as an interference boundary line, and an interference avoidance travel controller to control travel for avoiding interference with the interference boundary line.

Abstract: A cultivated land work vehicle includes a vehicle position computer, a travel controller to control travel of the body based on a vehicle position and target routes, and a replenishment mode executor to execute a replenishment travel mode to replenish the cultivated land work vehicle with agricultural material, during U-turn transition travel. In a first replenishment travel mode, reverse travel into the boundary area is performed after a starting point of the next travel route his reached, and forward travel to the starting point of the next travel route his performed after replenishment work is complete. In a second replenishment travel mode, reverse travel into the boundary area is performed before the starting point of the next travel route is reached, and forward travel to the starting point of the next travel route is performed after the replenishment work is complete.

Abstract: It is an object of the present invention to provide a detoxified secretome extract of a culture supernatant having high efficacy and high safety, and a method for producing the same. According to the present invention, provided is a detoxified secretome extract of a culture supernatant of mesenchymal stem cells or progenitor cells derived from the mesenchymal stem cells, wherein the detoxified secretome extract comprises at least one of IGFBP, HGF, VEGF, PDGF, EGF, KGF (FGF-7), PDGFR, TGF?, and TGF? secreted by the mesenchymal stem cells or the progenitor cells derived from the mesenchymal stem cells, and wherein lactic acid and ammonia that are metabolic waste products caused by the mesenchymal stem cells or the progenitor cells derived from the mesenchymal stem cells are removed from the detoxified secretome extract.

Abstract: A method for preparing a stromal vascular fraction from an adipose tissue, including a step of treating an adipose tissue with an enzyme solution containing a collagenase and a neutral protease, preferably an enzyme solution free of clostripain and thermolysin, and showing not less than 1 U neutral protease activity with respect to 10,000 U collagenase activity, and recovering cells is provided by the present invention.

Abstract: Medical tape suitable to be adhered onto a skin wound for healing of the skin wound or onto a scar for suppressing a thickening, an expansion and an extension of the scar after healing of the wound. The medical tape includes a flexible and stretchable substrate consisting of a plastic film or foil; a release paper which is adhered to one side of the substrate via a pressure-sensitive adhesive layer; and a peelable support consisting of two sheets of plastic films which are adhered to another side of the substrate via a silicone-coating layer and a slightly adhesive layer, in that order. The two sheets of plastic films are butted with each other at the midpoint of a longitudinal direction of the substrate, and over a widthwise direction of the substrate. The medical tape advantageously applies a shrinking force only to a wound surface or a scar surface.

Abstract: The purpose of the present invention is to provide a novel medicinal use in regeneration medicine, said medicinal use comprising using pluripotent stem cells (Muse cells). Provided is a cell preparation for treating skin ulcer, said cell preparation comprising SSEA-3 positive pluripotent stem cells isolated from a mesenchymal tissue of a living organism or cultured mesenchymal cells. The cell preparation according to the present invention is based on such mechanism of skin tissue regeneration that, when the Muse cells are administered to a skin ulcer site of a subject suffering from the aforesaid disease, the Muse cells differentiate into skin-constituting cells.

Abstract: The purpose of the present invention is to provide a novel medicinal use in regeneration medicine, said medicinal use comprising using pluripotent stem cells (Muse cells). Provided is a cell preparation for treating skin ulcer, said cell preparation comprising SSEA-3 positive pluripotent stem cells isolated from a mesenchymal tissue of a living organism or cultured mesenchymal cells. The cell preparation according to the present invention is based on such mechanism of skin tissue regeneration that, when the Muse cells are administered to a skin ulcer site of a subject suffering from the aforesaid disease, the Muse cells differentiate into skin-constituting cells.

Abstract: A parking evaluation device includes: a parking target position setting unit configured to set a parking target position; a parking path calculator configured to calculate a parking path to the parking target position; an own vehicle position calculator configured to calculate an own vehicle position that is a position of a vehicle during a parking operation by a driver; a difference calculator configured to calculate a path difference indicating a difference between the own vehicle position and the parking path; and an output controller configured to inform of first evaluation information on the parking operation, during the parking operation, the first evaluation information being based on the path difference.

Abstract: Medical tape suitable to be adhered onto a skin wound for healing of the skin wound or onto a scar for suppressing a thickening, an expansion and an extension of the scar after healing of the wound. The medical tape includes a flexible and stretchable substrate consisting of a plastic film or foil; a release paper which is adhered to one side of the substrate via a pressure-sensitive adhesive layer; and a peelable support consisting of two sheets of plastic films which are adhered to another side of the substrate via a silicone-coating layer and a slightly adhesive layer, in that order. The two sheets of plastic films are butted with each other at the midpoint of a longitudinal direction of the substrate, and over a widthwise direction of the substrate. The medical tape advantageously applies a shrinking force only to a wound surface or a scar surface.

Abstract: The purpose of the present invention is to provide a novel medicinal use in regeneration medicine, said medicinal use comprising using pluripotent stem cells (Muse cells). Provided is a cell preparation for treating skin ulcer, said cell preparation comprising SSEA-3 positive pluripotent stem cells isolated from a mesenchymal tissue of a living organism or cultured mesenchymal cells. The cell preparation according to the present invention is based on such mechanism of skin tissue regeneration that, when the Muse cells are administered to a skin ulcer site of a subject suffering from the aforesaid disease, the Muse cells differentiate into skin-constituting cells.

Abstract: The present invention provides a method for preparing homogeneous stem cells and/or precursor cells in a large amount, in a simple and efficient manner, from human (in particular, the subject per se). The present invention further provides a method for preparing tissue implant or graft in a large amount by the use of the stem cells and/or precursor cells of the present invention. The present inventors have unexpectedly discovered that an aspirate from liposuction contains a large number of stem cells and have established a method for preparing stem cells from such an aspirate from liposuction, and thereby achieved the above-mentioned object.

Abstract: A drug solution injection needle is provided that can not only inject a drug solution from multiple locations, but also restrict the depth of puncture by injection needles while preventing an observable wheal from being unlikely to form. The drug solution injection needle has multiple injection needles and a needle support for supporting the plurality of injection needles. The needle support has: a needle protruding surface from which the multiple injection needles protrude out; and an abutment fragment, which is formed in the needle protruding surface and abuts the skin to obstruct the multiple injection needles from entering the skin when the multiple injection needles have entered the skin to a predetermined depth. The abutment section is provided away from the injection needles such that an observable wheal is formed around each of the multiple injection needles.

Abstract: The present invention provides a simple method for controlled differentiation of adipose-derived precursor cells. A method is provided for preparing a differentiated cell. The method comprises A) obtaining a mixture by mixing a) an adipose-derived precursor cell and b) a differentiated cell corresponding to a desired site; and B) culturing the mixture under sufficient conditions which allow the adipose-derived precursor cell to differentiate. The present invention also provides a composition for cell implantation comprising a) an adipose-derived precursor cell and b) a differentiated cell corresponding to a desired site.

Abstract: The present invention provides a simple method for controlled differentiation of adipose-derived precursor cells. A method is provided for preparing a differentiated cell. The method comprises A) obtaining a mixture by mixing a) an adipose-derived precursor cell and b) a differentiated cell corresponding to a desired site; and B) culturing the mixture under sufficient conditions which allow the adipose-derived precursor cell to differentiate. The present invention also provides a composition for cell implantation comprising a) an adipose-derived precursor cell and b) a differentiated cell corresponding to a desired site.

Abstract: The present invention provides a method for preparing homogeneous stem cells and/or precursor cells in a large amount, in a simple and efficient manner, from human (in particular, the subject per se). The present invention further provides a method for preparing tissue implant or graft in a large amount by the use of the stem cells and/or precursor cells of the present invention. The present inventors have unexpectedly discovered that an aspirate from liposuction contains a large number of stem cells and have established a method for preparing stem cells from such an aspirate from liposuction, and thereby achieved the above-mentioned object.

Abstract: An ink cartridge is removably attached to a serial printer. The ink cartridge has a memory device in which information on the ink cartridge is stored. The information may include information such as viscosity, temperature coefficient, the hue and brightness of color ink, various user's settings of density of a printed image and color tone of a printed color image, and identification data indicative of a kind of the ink cartridge. A controller in the printer determines whether the attached cartridge is suitable for use with the printer, by comparing the identification data read from the ink cartridge with the reference data stored in the printer. The information may also include data of a maximum count of dots that the ink cartridge is capable of printing and data of a cumulative count of printed dots that the cartridge has printed.

Abstract: An ink jet printer has a first transporting section adapted to transport a medium on which information is printed. The first transporting section has a first contact area in contact with the medium. A second transporting section is adapted to transport the medium and has a second contact area in contact with the medium. The second contact area is smaller than the first contact area. A selector selectively causes the first and second transporting sections to move into contact engagement with the medium to transport the medium.

Abstract: An ink cassette is used in an ink jet printer and has nozzles through which ink is ejected. The ink cassette has a pair of nozzle levers with a cap formed between their free ends. The cap closes the nozzles when the nozzle levers pivot to a closing position and leaves the nozzles exposed when the levers pivot to an opening position. A carriage unit receives the ink cassette therein and moves between a print area and a non-print area. The carriage unit has supports on which the ink cassette pivots between a first position and a second position. When the ink cassette pivots to the first position, the ink cassette is engaged with a lock lever which holds the ink cassette in position, and the nozzle lever is engaged with lugs formed on the carriage unit which cause the nozzle levers to pivot to the opening position when the ink cassette is moved to the first position.